Dr. Salvador Eugenio C. Caoili, Dr. Ruby Anne N. King, Dr. Fresthel Monica M. Climacosa
The invention provides peptide-based antigenic constructs comprising a plurality of monomeric units and recognized by immunoglobulins that bind to protein epitopes of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2); methods for producing said constructs using peptide precursors that comprise artificial sequences, said monomeric units being derived from said precursors; methods and testing systems for detecting said immunoglobulins; and use of said constructs in processes for detecting and producing said immunoglobulins.
- New materials for diagnostics
- Detection of antibodies against SARS-CoV-2
- Low-cost antibody test kit
MARKET APPLICATIONS AND COMMERCIAL OPPORTUNITIES
In 2020, SARS-CoV-2 was declared by the World Health Organization as a global pandemic. Numerous kits have been commercialized in the market as rapid diagnostic tests (RDTs) and other systems for the detection of SARS-CoV-2 antigens and anti-SARS-CoV-2 antibodies. This technology aims to enable the development of such systems using low-cost materials to be manufactured in the Philippines and elsewhere.
The technology presented can be utilized in R&D and clinical/molecular diagnostic laboratories.
The technology is currently under further research and development.
- Patent Application Filed (Application No. 1-2020-050482)
- Patent Cooperation Treaty Application Filed
TYPE OF PARTNERSHIP BEING SOUGHT
Licensing. Looking for partners or collaborators for clinical validation trials, licensees.